GPX4 and liver disorder: Extensive studies have shown that GPX4 is involved in the occurrence and development of a variety of inflammatory diseases and liver diseases (Xie et al., 2023), but the potential significance and prognostic value of GPX4 in HBV-ACLF patients have not been determined.